Zicam and Orajel
Allegations: Misleadingly marketing products as safe without disclosing that they have been contaminated with fungi that could lead to adverse health consequences
In December 2015, a class-action lawsuit was filed against Zicam for allegedly deceptively marketing Zicam Pre-Cold Medicine products – including RapidMelts, Oral Mist, Ultra Crystals, Lozenges, and Chewables – as having the ability to treat cold symptoms without adequate evidence to support such claims and when scientific evidence shows that the products are “nothing more than a placebo.” (Gulkis et al v. Zicam LLC and Matrixx Initiatives, Inc., Case No. 15-cv-9843, S. D. NY.)
For more information about other class-action lawsuits regarding products claiming to treat cold symptoms and TINA.org’s coverage of them, click here.
Allegations: Misleadingly marketing products as safe without disclosing that they have been contaminated with fungi that could lead to adverse health consequences
Allegations: Falsely advertising that products are “clinically proven to shorten colds” when there is no scientific evidence to support such claims
MADISON, CONN. Feb. 11, 2026 – A company calling itself “Patent & Trademark Office” is violating the FTC’s Impersonation Rule as well as the FTC Act by falsely posing as…
Complaint to FTC cites violations of agency’s Impersonation Rule.
TINA.org digs into shop’s purported Newport roots, and more.
Here are some of TINA.org’s favorites that are set to air during The Big Game.
TINA.org staffer gets surprise charge.